A detailed history of Synovus Financial Corp transactions in Pfizer Inc stock. As of the latest transaction made, Synovus Financial Corp holds 694,315 shares of PFE stock, worth $19.4 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
694,315
Previous 710,988 2.35%
Holding current value
$19.4 Million
Previous $23.6 Million 18.3%
% of portfolio
0.25%
Previous 0.27%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $431,663 - $495,688
-16,673 Reduced 2.35%
694,315 $19.3 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $294,714 - $344,491
9,184 Added 1.31%
710,988 $23.6 Million
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $383,775 - $444,018
10,625 Added 1.54%
701,804 $25.7 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $363,490 - $473,211
-9,228 Reduced 1.32%
691,179 $28.2 Million
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $474,864 - $619,883
11,374 Added 1.65%
700,407 $35.9 Million
Q3 2022

Oct 27, 2022

BUY
$43.76 - $53.42 $519,737 - $634,469
11,877 Added 1.75%
689,033 $30.2 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $1.07 Million - $1.27 Million
23,051 Added 3.52%
677,156 $35.5 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $3.15 Million - $3.91 Million
-68,958 Reduced 9.54%
654,105 $33.9 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $472,824 - $700,883
11,443 Added 1.61%
723,063 $42.7 Million
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $746,181 - $958,534
19,011 Added 2.74%
711,620 $30.6 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $144,465 - $163,655
4,023 Added 0.58%
692,609 $27.1 Million
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $64,870 - $73,160
-1,937 Reduced 0.28%
688,586 $24.9 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $379,215 - $482,204
11,330 Added 1.67%
690,523 $25.4 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $15,430 - $18,103
-486 Reduced 0.07%
679,193 $24.9 Million
Q2 2020

Aug 10, 2020

SELL
$30.12 - $36.54 $4.46 Million - $5.41 Million
-148,136 Reduced 17.89%
679,679 $22.2 Million
Q1 2020

Apr 24, 2020

BUY
$27.03 - $38.62 $4.11 Million - $5.87 Million
151,886 Added 22.47%
827,815 $27 Million
Q4 2019

Feb 06, 2020

BUY
$32.92 - $37.36 $231,921 - $263,201
7,045 Added 1.05%
675,929 $26.5 Million
Q3 2019

Nov 01, 2019

BUY
$32.49 - $42.13 $366,974 - $475,858
11,295 Added 1.72%
668,884 $24 Million
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $53,177 - $59,705
-1,438 Reduced 0.22%
657,589 $28.5 Million
Q1 2019

May 09, 2019

SELL
$37.5 - $41.2 $387,450 - $425,678
-10,332 Reduced 1.54%
659,027 $27.9 Million
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $954,209 - $1.09 Million
-24,804 Reduced 3.57%
669,359 $29.2 Million
Q3 2018

Nov 01, 2018

BUY
$34.47 - $41.81 $235,774 - $285,980
6,840 Added 1.0%
694,163 $30.6 Million
Q2 2018

Aug 01, 2018

SELL
$32.98 - $35.16 $97,620 - $104,073
-2,960 Reduced 0.43%
687,323 $24.9 Million
Q1 2018

May 07, 2018

BUY
$31.91 - $37.02 $90,209 - $104,655
2,827 Added 0.41%
690,283 $24.5 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $402,346 - $426,903
12,097 Added 1.79%
687,456 $24.9 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $20.9 Million - $23.1 Million
675,359
675,359 $24.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.